Candel Therapeutics, Inc. CADL Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Candel Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s total operating expenses?
- Candel Therapeutics, Inc. (CADL) reported total operating expenses of $16.28M in Q1 2026.
- How has Candel Therapeutics, Inc.'s total operating expenses changed year-over-year?
- Candel Therapeutics, Inc.'s total operating expenses increased by 100.3% year-over-year, from $8.13M to $16.28M.
- What is the long-term trend for Candel Therapeutics, Inc.'s total operating expenses?
- Over 4 years (2021 to 2025), Candel Therapeutics, Inc.'s total operating expenses has grown at a 16.9% compound annual growth rate (CAGR), from $25.85M to $48.27M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.